Skip to main content
PMC home page
AAPS PharmSci logoLink to AAPS PharmSci
. 2003 Feb 16;5(2):61–71. doi: 10.1208/ps050214

Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin

Mohammad Al-Khalili 1,✉, Victor M Meidan 2, Boeena B Michniak 2
PMCID: PMC2751522  PMID: 12866941

Abstract

The transdermal delivery of buspirone hydrochloride across hairless mouse skin and the combined effect of iontophoresis and terpene enhancers were evaluated in vitro using Franz diffusion cells. Iontophoretic delivery was optimized by evaluating the effect of drug concentration, current density, and pH of the vehicle solution. Increasing the current density from 0.05 to 0.1 mA/cm2 resulted in doubling of the iontophoretic flux of buspirone hydrochloride, while increasing drug concentration from 1% to 2% had no effect on flux. Using phosphate buffer to adjust the pH of the drug solution decreased the buspirone hydrochloride iontophoretic flux relative to water solutions. Incorporating buspirone hydrochloride into ethanol:water (50:50 vol/vol) based gel formulations using carboxymethylcellulose and hydroxypropylmethylcellulose had no effect on iontophoretic delivery. Incorporation of three terpene enhancers (menthol, cineole, and terpineol) into the gel and when combined with iontophoresis it was possible to deliver 10 mg/cm2/day of buspirone hydrochloride.

Keywords: iontophoresis, terpene, buspirone hydrochloride, gel, transdermal

References

  • 1.Balon R. Buspirone in the treatment of separation anxiety in an adolescent boy. J Clin Psychopharmacol. 1994;14:360–361. doi: 10.1097/00004714-199410000-00016. [DOI] [PubMed] [Google Scholar]
  • 2.Ratey JJ, Sovner R, Mikkelsen E, Chmielinski HE. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. J Clin Psychiatry. 1989;50:382–384. [PubMed] [Google Scholar]
  • 3.Realmuto GM, August GJ, Garfinkel BD. Clinical effect of buspirone in autistic children. J Clin Psychopharmacol. 1989;9:122–125. doi: 10.1097/00004714-198904000-00009. [DOI] [PubMed] [Google Scholar]
  • 4.Dollery C. Therapeutic Drugs. 2nd ed. Edinburgh, Scotland: Churchill Livingston; 1999. [Google Scholar]
  • 5.Valenta C, Siman U, Kratzel M, Hadgraft J. The dermal delivery of lignocaine: influence of ion pairing. Int J Pharm. 2000;197:77–85. doi: 10.1016/S0378-5173(99)00453-6. [DOI] [PubMed] [Google Scholar]
  • 6.Smith JC, Irwin WJ. Ionisation and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin. Int J Pharm. 2000;210:69–82. doi: 10.1016/S0378-5173(00)00561-5. [DOI] [PubMed] [Google Scholar]
  • 7.Anliker M, Maibach HI, Singh P. Transdermal iontophoresis and solute penetration across excised human skin. Curr Prob Dermatol. 1995;22:184–188. doi: 10.1002/jps.2600841115. [DOI] [PubMed] [Google Scholar]
  • 8.Guy RH. Iontophoresis, recent developments. J Pharm Pharmacol. 1998;50:371–374. doi: 10.1111/j.2042-7158.1998.tb06875.x. [DOI] [PubMed] [Google Scholar]
  • 9.Banga AK. Electrically Assisted Transdermal and Topical Drug Delivery. London, England: Taylor and Francis; 1998. [Google Scholar]
  • 10.Guy RH, Kalia YN, Delgado-Charro MB, Merino V, Lopez A, Marro D. Iontophoresis: electrorepulsion and electroosmosis. J Control Release. 2000;64:129–132. doi: 10.1016/S0168-3659(99)00132-7. [DOI] [PubMed] [Google Scholar]
  • 11.Cardoso SG, Schapoval EE. Stability assay of buspirone hydrochloride in tablets. Pharmazie. 1998;53:349–351. [Google Scholar]
  • 12.Wearley L, Liu JC, Chien YW. Iontophoresis-facilitated transdermal delivery of verapamil, II: factors affecting the reversibility of skin permeability. J Control Release. 1989;9:231–242. doi: 10.1016/0168-3659(89)90091-6. [DOI] [Google Scholar]
  • 13.Padmanabhan RV, Phipps JB, Lattin GA, Sawchuk RJ. In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone. J Control Release. 1990;11:123–135. doi: 10.1016/0168-3659(90)90126-E. [DOI] [Google Scholar]
  • 14.Miller LL, Smith GA. Iontophoretic transport of acetate and carboxylate ions through hairless mouse skin: cation exchange membrane model. Int J Pharm. 1989;49:15–22. doi: 10.1016/0378-5173(89)90147-6. [DOI] [Google Scholar]
  • 15.Bellantone NH, Rim S, Francoeur ML, Rasadi B. Enhanced percutaneous absorption via iontophoresis, I: evaluation of an in vitro system and transport of a model compound. Int J Pharm. 1986;30:63–72. doi: 10.1016/0378-5173(86)90136-5. [DOI] [Google Scholar]
  • 16.Sage BH. Iontophoresis. In: Smith EW, Maibach HI, editors. Percutaneous Penetration Enhancers. Boca Raton, FL: CRC; 1995. pp. 361–365. [Google Scholar]
  • 17.Hladky SB, Haydon DA. Ion transfer across lipid membranes in the presence of gramicidin A, I: studies of the unit conductance channel. Biochim Biophys Acta. 1972;274:294–312. doi: 10.1016/0005-2736(72)90178-2. [DOI] [PubMed] [Google Scholar]
  • 18.Lauger P. Ion transport through pores: a rate-theory analysis. Biochim Biophys Acta. 1973;311:423–441. doi: 10.1016/0005-2736(73)90323-4. [DOI] [PubMed] [Google Scholar]
  • 19.Yoshida NH, Roberts MS. Role of conductivity in iontophoresis, II: anodal iontophoretic transport of phenylethylamine and sodium across excised human skin. J Pharm Sci. 1994;83:344–350. doi: 10.1002/jps.2600830316. [DOI] [PubMed] [Google Scholar]
  • 20.Yoshida NH, Roberts MS. Prediction of cathodal iontophoretic transport of various anions across excised skin from different vehicles using conductivity measurements. J Pharm Pharmacol. 1995;47:883–890. doi: 10.1111/j.2042-7158.1995.tb03265.x. [DOI] [PubMed] [Google Scholar]
  • 21.Hinz RS, Lorence CR, Price M, Guy RH, Kim A. Convective solvent flow across the skin during iontophoresis. Crit Rev Toxicol. 1993;23:171–235. doi: 10.3109/10408449309117116. [DOI] [PubMed] [Google Scholar]
  • 22.Glikfeld P, Guy RH, Burnette RR. Characterization of the permselective properties of excised human skin during iontophoresis. Pharm Res. 1993;10:1751–1755. doi: 10.1023/A:1018926215306. [DOI] [PubMed] [Google Scholar]
  • 23.Guy RH, Golden GM, Mak VH, Francoeur ML, Delgado-Charro MB. Characterization of convective solvent flow during iontophoresis. J Invest Dermatol. 1994;103:233–239. doi: 10.1111/1523-1747.ep12393214. [DOI] [PubMed] [Google Scholar]
  • 24.Hirvonen J, Kalia YN, Guy RH. Transdermal delivery of peptides by iontophoresis. Pharm Res. 1996;13:1765–1769. doi: 10.1023/A:1016060403438. [DOI] [PubMed] [Google Scholar]
  • 25.Langer R, Brown L, Edelman E. Controlled release and magnetically modulated release systems for macromolecules. Methods Enzymol. 1985;112:399–422. doi: 10.1016/S0076-6879(85)12032-X. [DOI] [PubMed] [Google Scholar]
  • 26.Vazquez MJ, Perez-Marcos B, Gomez-Amoza JL, Martinez-Pacheco R, Concheiro A. Influence of technological variables on release of drugs from hydrophilic matrices. Drug Dev Ind Pharm. 1992;18:1355–1375. doi: 10.3109/03639049209046332. [DOI] [Google Scholar]
  • 27.Doliwa A, Santoyo S, Ygartua P. Effect of passive and iontophoretic skin pretreatments with terpenes on the in vitro skin transport of piroxicam. Int J Pharm. 2001;229:37–44. doi: 10.1016/S0378-5173(01)00849-3. [DOI] [PubMed] [Google Scholar]
  • 28.Doliwa A, Santoyo S, Ygartua P. Transdermal iontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes. Drug Dev Ind Pharm. 2001;27:751–758. doi: 10.1081/DDC-100107238. [DOI] [PubMed] [Google Scholar]
  • 29.Fang JY, Hsu LR, Huang YB, Tsai YH. Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. Int J Pharm. 1999;180:137–149. doi: 10.1016/S0378-5173(98)00287-7. [DOI] [PubMed] [Google Scholar]
  • 30.Fang JY, Sung KC, Lin HH, Fang CL. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies. Int J Pharm. 1999;178:83–92. doi: 10.1016/S0378-5173(98)00361-5. [DOI] [PubMed] [Google Scholar]
  • 31.Doelker E. Water-swollen cellulose derivatives in pharmacy. In: Pappas NA, editor. Hydrogels in Medicine and Pharmacy. Vol 2: Polymers. Boca Raton, FL: CRC; 1987. pp. 115–160. [Google Scholar]
  • 32.Chu DL, Chiou HJ, Wang DP. Characterization of transdermal delivery of nefopam hydrochloride under iontophoresis. Drug Dev Ind Pharm. 1994;20:2775–2785. doi: 10.3109/03639049409042680. [DOI] [Google Scholar]
  • 33.Fang JY, Huang YB, Wu PC, Tsai YH. Transdermal iontophoresis of sodium nonivamide acetate, II: optimization and evaluation on solutions and gels. Int J Pharm. 1996;145:175–186. doi: 10.1016/S0378-5173(96)04767-9. [DOI] [Google Scholar]
  • 34.Brouneus F, Karami K, Beronius P, Sundelof L. Diffusive transport properties of some local anesthetics applicable for iontophoretic formulation of the drugs. Int J Pharm. 2001;218:57–62. doi: 10.1016/S0378-5173(01)00612-3. [DOI] [PubMed] [Google Scholar]
  • 35.Fang JY, Kuo CT, Huang YB, Wu PC, Tsai YH. Transdermal delivery of sodium nonivamide propionate by iontophoresis. Biol Pharm Bull. 1998;21:1117–1120. doi: 10.1248/bpb.21.1117. [DOI] [PubMed] [Google Scholar]
  • 36.Ganga S, Ramarao P, Singh J. Effect of Azone on the iontophoretic transdermal delivery of metoprolol tartrate through human epidermis in vitro. J Control Release. 1996;42:57–64. doi: 10.1016/0168-3659(96)01351-X. [DOI] [Google Scholar]
  • 37.Kalia YN, Guy RH. The electrical characteristics of human skin in vivo. Pharm Res. 1995;12:1605–1613. doi: 10.1023/A:1016228730522. [DOI] [PubMed] [Google Scholar]
  • 38.Williams AC, Barry BW. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm Res. 1991;8:17–24. doi: 10.1023/A:1015813803205. [DOI] [PubMed] [Google Scholar]
  • 39.Okabe H, Obata Y, Takayama K, Nagai T, Quan DY. Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes: enhancing effect of piperidone derivatives on the percutaneous absorption of indomethacin. Drug Des Deliv. 1990;6:229–238. [PubMed] [Google Scholar]
  • 40.Moghimi RH, Williams AC, Barry BW. A lamellar matrix model for stratum corneum intercellular liplids, V: effects of terpene penetration enhancers on the structure and thermal behaviour of the matrix. Int J Pharm. 1997;146:41–54. doi: 10.1016/S0378-5173(96)04766-7. [DOI] [Google Scholar]
  • 41.El-Kattan AF, Asbill CS, Kim N, Michniak BB. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm. 2001;215:229–240. doi: 10.1016/S0378-5173(00)00699-2. [DOI] [PubMed] [Google Scholar]
  • 42.Okabe H, Takayama K, Ogura A, Nagai T. Effect of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Des Deliv. 1989;4:313–321. [PubMed] [Google Scholar]
  • 43.Arellano A, Santoyo S, Martin C, Ygartua P. Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int J Pharm. 1996;145:130–141. [Google Scholar]

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES